#sanofi — Public Fediverse posts

Press Release: Sanofi evolves its Executive Committee to

Sanofi evolves its Executive Committee to support its next strategic chapter Paris, July 21, 2026. Sanofi today announced…
#France #FR #Europe #EU #Sanofi #ParisStockExchange:SAN #SanofiWinthropIndustrie
https://www.europesays.com/france/54702/

Sanofi publicly reprimanded after UK code breaches over Beyfortus promotion

French pharma major Sanofi (Euronext Paris: SAN) has been publicly reprimanded after the UK Prescription Medicines Code of…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/54684/

Sanofi stock trades steady as vaccine and specialty care revenue underpin valuation

Sanofi stock, tied to the French healthcare group Sanofi S.A. (ISIN FR0000127771), stands on a large global footprint…
#France #FR #Europe #EU #Sanofi #FR0000127771 #Vivendi
https://www.europesays.com/france/54543/

Sanofi stock falls after a quarterly revenue update

Sanofi (FR0000127771) remains a large-cap European health-care name, but the latest verified search results available in this call…
#France #FR #Europe #EU #Sanofi #FR0000127771 #Vivendi
https://www.europesays.com/france/54523/

Sanofi stock trades steadily as Dupixent growth supports earnings outlook

Sanofi stock is trading steadily as investors weigh the French pharmaceutical group’s (ISIN FR0000120578) expanding specialty medicines portfolio…
#France #FR #Europe #EU #Sanofi #FR0000120578
https://www.europesays.com/france/54507/

Lobbying Update: $920,000 of SANOFI US SERVICES INC lobbying was just disclosed

$920,000 of SANOFI US SERVICES INC lobbying was just disclosed, from Q2 of 2026, in a new Lobbying…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/54331/

Sanofi stock trades steadily as oncology and immunology pipeline shapes outlook

Sanofi stock offers investors exposure to a large, diversified European pharmaceutical group whose earnings and cash flows are…
#France #FR #Europe #EU #Sanofi #FR0000127771 #Vivendi
https://www.europesays.com/france/54156/

Sanofi stock trades steady as vaccines and specialty care drive earnings momentum

Sanofi stock is supported by earnings momentum as the French healthcare group Sanofi S.A. (ISIN FR0000127771) leans on…
#France #FR #Europe #EU #Sanofi #FR0000127771 #Vivendi
https://www.europesays.com/france/54093/

https://www.europesays.com/ch/105683/ Novartis Earnings Preview: Can New Medicines Offset Generic Pressure and Growing U.S. Pricing Risks? #AstraZeneca #avidi #Novartis #NovartisAG #NovoNordisk #RocheHoldingAG #Sanofi #stocks #weekly #YahooFeed

Cancer Therapy Market is Going to Boom: New Report Reveals Massive Growth Potential 2026-2033

Cancer Therapy Market The cancer therapy market is estimated to be valued at USD 260.52 Bn in 2026…
#France #FR #Europe #EU #Sanofi #CancerTherapyMarket
https://www.europesays.com/france/53993/

Sanofi stock steadies as Dupixent growth supports earnings outlook

Sanofi (ISIN FR0000120578) stock is supported by a sizeable earnings base from 2025 and by continued growth of…
#France #FR #Europe #EU #Sanofi #FR0000120578
https://www.europesays.com/france/53768/

Sanofi stock trades steadily as vaccines and specialty care support earnings

Sanofi stock represents one of Europes larger global pharmaceutical positions, with the French healthcare group (ISIN FR0000127771) combining…
#France #FR #Europe #EU #Sanofi #FR0000127771 #Vivendi
https://www.europesays.com/france/53759/

ADEL Nears IPO on Sanofi Deal, Eyes New Tech Transfer Within 1-2 Years

ADEL CEO Yoon Seung-yong explains the Alzheimer’s disease drug candidate “ADEL-Y01” at the company’s headquarters in Gangdong-gu, Seoul,…
#France #FR #Europe #EU #Sanofi #ADEL #ADEL-Y01 #Alzheimer'sdiseasetreatment #ApoE4antibody #blood-brainbarrierplatform #KOSDAQIPO #technologytransfer
https://www.europesays.com/france/53734/

Sanofi stock trades steady as recent earnings and pipeline shape outlook

Sanofi stock, tied to the French healthcare group Sanofi S.A. (ISIN FR0000127771), reflects a balance between stable revenue…
#France #FR #Europe #EU #Sanofi #FR0000127771 #Vivendi
https://www.europesays.com/france/53668/

Weil Advises Sanofi in its $2.2 Billion Acquisition of Dynavax

Weil is advising Sanofi in its agreement to acquire Dynavax Technologies Corporation, a publicly traded vacc…
#France #FR #Europe #EU #Sanofi #Antitrust #AntitrustCartelandInvestigations #AntitrustLitigation #capitalmarkets #D.C. #ExecutiveCompensation&Benefits #Mergers&Acquisitions #NewYork #Privacy&Cybersecurity #realestate #RegulatoryTransactions #Tax #Technology&IPTransactions #Washington
https://www.europesays.com/france/53656/

Sanofi stock holds steady as investors await new data

Sanofi stock remains centered on the companys latest disclosed financial base, with the French group (ISIN FR0000120578) reporting…
#France #FR #Europe #EU #Sanofi #FR0000120578
https://www.europesays.com/france/53652/

Devika Gupta Joins Sanofi as Head of Value for Healthcare Systems & Economics

Morristown, New Jersey, United States, July 2026 — Sanofi has appointed Devika Gupta as Head of Value for…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/53559/

Sanofi stock trades steady as latest quarterly results highlight vaccine and specialty care momentum

Sanofi stock offers investors a picture shaped by recent earnings metrics rather than intraday swings. The French healthcare…
#France #FR #Europe #EU #Sanofi #FR0000127771 #Vivendi
https://www.europesays.com/france/53508/

Sanofi stock trades steady as oncology and vaccines pipeline underpins long term growth prospects

Sanofi stock is tied to the performance of the French healthcare group Sanofi S.A. (ISIN FR0000127771), whose latest…
#France #FR #Europe #EU #Sanofi #FR0000127771 #Vivendi
https://www.europesays.com/france/53402/

Sanofi stock trades steady as new data and pipeline updates frame valuation

Sanofi stock is underpinned by a broad pharmaceuticals and vaccines portfolio, while recent earnings and guidance set the…
#France #FR #Europe #EU #Sanofi #FR0000127771 #Vivendi
https://www.europesays.com/france/53380/

Sanofi stock trades steady as diabetes and immunology pipeline underpins long term growth

Sanofi stock sits in a zone where recent earnings trends and its expanding specialty medicines pipeline are pulling…
#France #FR #Europe #EU #Sanofi #FR0000127771 #Vivendi
https://www.europesays.com/france/53176/

Sanofi stock holds firm as Dupixent drives growth and Q1 2026 earnings rise

Sanofi (ISIN FR0000120578) stock is supported by continued growth in key specialty medicines, after the Paris-based pharmaceutical group…
#France #FR #Europe #EU #Sanofi #FR0000120578
https://www.europesays.com/france/53140/

Aqemia and Sanofi Expand Their Research Collaboration

A new target nomination and a milestone payment mark the next step of the multi-year partnership first announced…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/52938/

Aqemia Expands Sanofi AI Drug Discovery Deal

Aqemia and Sanofi have expanded their multi-year drug discovery collaboration, with the France-based AI company announcing the nomination…
#France #FR #Europe #EU #Sanofi
https://www.europesays.com/france/52924/

Breakthroughs belong to every patient – Sanofi and Semmelweis sign strategic agreement – Semmelweis University

On behalf of the Sanofi Group, Sanofi-Aventis Ltd. and CHINOIN Ltd. signed a strategic cooperation agreement with…
#France #FR #Europe #EU #Sanofi #innovation #internationalrelations #Partnership #Research&Development #SemmelweisWorld #X-Nyitólap
https://www.europesays.com/france/52906/

Sanofi strengthens its research alliance with Aqemia

Aqemia, a drug discovery company that combines generative AI and quantum physics to design small-molecule medicines, is announcing…
#France #FR #Europe #EU #Sanofi #Markets
https://www.europesays.com/france/52866/

Sanofi stock advances on earnings and pipeline momentum

Sanofi (FR0000127771) is anchored by €7.3 billion in first-half 2026 revenue and 32.4% growth in business operating income,…
#France #FR #Europe #EU #Sanofi #FR0000127771 #Vivendi
https://www.europesays.com/france/52850/

Sanofi gets FDA approval for Sarclisa on-body injector | SNY SEC Filing

“The introduction of Sarclisa Escena with the innovative CirCLIQ on-body injector represents a significant advancement in multiple myeloma…
#France #FR #Europe #EU #Sanofi #CirCLIQ #EnableInjections #enFuse #FDAapproval #multiplemyeloma #on-bodyinjector #phase3IRAKLIA #SarclisaEscena #SNY
https://www.europesays.com/france/52785/

Sanofi stock trades steadily as Dupixent growth offsets currency headwinds

Sanofi (ISIN FR0000127771) stock is anchored by growing specialty-care earnings, with the French pharmaceutical group reporting second-quarter 2026…
#France #FR #Europe #EU #Sanofi #FR0000127771 #Vivendi
https://www.europesays.com/france/52776/

Say what you like about the competition! No fines for Sanofi in EC disparagement case, Sean-Paul Brankin

On 26 June, the European Commission (EC) announced the opening of a competition law investigation into allegations of a campaign…
#France #FR #Europe #EU #Sanofi #Biotech #competitionlaw #LifeSciences #lifesciencesregulatory
https://www.europesays.com/france/52762/

Sanofi joins the mRNA vaccine patent wars

Why it matters: The lawsuits give Sanofi another route to extract value from the mRNA technology it acquired…
#France #FR #Europe #EU #Sanofi #intellectualproperty
https://www.europesays.com/france/52196/

Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi

Mechelen, Belgium; July 13, 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that following…
#France #FR #Europe #EU #Sanofi #Announces #Appointment #as #at #board #following #Fontoura #from #global #has #head #his #Its #Lakefront #of #Paulo #R&D #Resigned
https://www.europesays.com/france/50876/

https://www.europesays.com/es/654908/ “En enfermedades raras, la posibilidad de intervenir a nivel genético es prometedora” #A1 #EnfermedadesRaras #ES #España #Health #Laboratorios #Salud #Sanofi #Spain

Sanofi (ENXTPA:SAN) Wins FDA Nod For Sarclisa Escena As EU Opens Antitrust Probe

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
#France #FR #Europe #EU #Sanofi #antitrustinvestigation #fluvaccine #SarclisaEscena #SimplyWallSt #TheEuropeanCommission
https://www.europesays.com/france/49810/

Sanofi (ENXTPA:SAN) Wins FDA Nod For Sarclisa Escena As EU Opens Antitrust Probe

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
#Europe #EU #antitrustinvestigation #EuropeanUnion #fluvaccine #Sanofi #SarclisaEscena #SimplyWallSt #TheEuropeanCommission
https://www.europesays.com/europe/91647/

ADOCIA Announces the Expiration of Exclusive Right to Negotiate Partnership for M1Pram with SANOFI

LYON, France, July 03, 2026–(BUSINESS WIRE)–Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC, the “Company”), a clinical-stage biopharmaceutical…
#France #FR #Europe #EU #Sanofi #Adocia #EuronextParis #exclusivityagreement #globalrights #OlivierSoula #partnershipagreement #researchanddevelopment #type1diabetes
https://www.europesays.com/france/48313/

Sanofi posts positive Nexviazyme phase 3 IOPD data | SNY SEC Filing

About Sanofi Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling…
#France #FR #Europe #EU #Sanofi #Baby-COMET #biopharma #enzymereplacementtherapy #infantile-onsetPompe #labelextension #Nexviazyme #phase3trial #Pompedisease #SNY
https://www.europesays.com/france/47935/

ADOCIA Announces the Expiration of Exclusive Right to Negotiate Partnership for M1Pram with SANOFI

LYON, France, July 03, 2026–(BUSINESS WIRE)–Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC, the “Company”), a clinical-stage biopharmaceutical…
#France #FR #Europe #EU #Sanofi #Adocia #EuronextParis #exclusivityagreement #globalrights #OlivierSoula #partnershipagreement #researchanddevelopment #type1diabetes
https://www.europesays.com/france/45649/

Monroe County vaccine plant gets $10.6 million boost

THE LANCASTER COUNTY SOLID WASTE MANAGEMENT AUTHORITY SAYING THEY WILL BE PART OF THE PROCE…
#France #FR #Europe #EU #Sanofi #$10.6million #Carbonemissions #Commonwealth #dehydrators #eggwaste #fertilizedeggs #fluvaccine #JoshShapiro #LifeSciences #manufacturingplant #monroecounty #naturalgas #paddledryer #Pennsylvania #Shapiroadministration #Swiftwater #vaccinedoses #vaccinemanufacturing #vaccineplant
https://www.europesays.com/france/44496/

Sanofi (ENXTPA:SAN) Faces EU Antitrust Probe As Nexviazyme Trial Delivers Positive Data

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
#France #FR #Europe #EU #Sanofi #antitrustinvestigation #EuropeanCommission #EuropeanEconomicArea #fluvaccine #Pompedisease #rarediseases #SimplyWallSt
https://www.europesays.com/france/43941/

Sanofi (ENXTPA:SAN) Faces EU Antitrust Probe As Nexviazyme Trial Delivers Positive Data

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
#Europe #EU #antitrustinvestigation #EuropeanCommission #europeaneconomicarea #EuropeanUnion #fluvaccine #Pompedisease #rarediseases #Sanofi #SimplyWallSt
https://www.europesays.com/europe/82995/

Sanofi Pasteur receives $10.6M RISE PA grant

Listen to this article State officials visited the Sanofi Pasteur‘s Swiftwater vaccine manufacturing facility on Friday to announce…
#France #FR #Europe #EU #Sanofi #influenzavaccine #monroecounty #RISEPAgrant #SanofiPasteur #Swiftwater #vaccinemanufacturing
https://www.europesays.com/france/43582/

EU Commission launches antitrust investigation into Sanofi

The logo of the French drug manufacturer Sanofi, taken during a general meeting of the pharmaceutical company. (is…
#France #FR #Europe #EU #Sanofi #antitrustinvestigation #antitrustlaw #drugmanufacturer #eucommission #EuropeanUnion #fluvaccine
https://www.europesays.com/france/43083/

EU Commission launches antitrust investigation into Sanofi

The logo of the French drug manufacturer Sanofi, taken during a general meeting of the pharmaceutical company. (is…
#Europe #EU #EuropeanCommission #antitrustinvestigation #AntitrustLaw #drugmanufacturer #EUCommission #EuropeanUnion #fluvaccine #Sanofi
https://www.europesays.com/europe/81560/

Press Release: Sanofi Foundation opens new chapter centered on future generations

Sanofi Winthrop Industrie Sanofi Foundation opens new chapter centered on future generations Paris, June 25, 2026. The Sanofi Foundation…
#France #FR #Europe #EU #Sanofi #CerebralPalsyFoundation #foundation #healthcareprofessionals #humanitarianaction #humanitarianchallenges #humanitariancommitment #longstandingcommitment #SanofiFoundation #theFoundation
https://www.europesays.com/france/42613/

Sanofi wins key EU, Japan drug approvals and new R&D head | SNY SEC Filing

About Sanofi Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling…
#France #FR #Europe #EU #Sanofi #Cenrifki #drugapprovals #Form6-K #immunethrombocytopenia #multiplemyeloma #multiplesclerosis #PauloFontoura #Sarclisa #SNY #Wayrilz
https://www.europesays.com/france/40606/

Sanofi (ENXTPA:SAN) Wins Two Drug Approvals In Japan And The EU

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide. Sanofi secured approval in Japan for Wayrilz (rilzabrutinib) to treat chronic immune thrombocytopenia. Cenrifki (tolebr…
#Japan #JP #JapanNews #immunethrombocytopenia #marketedproducts #news #Sanofi
https://www.alojapan.com/1502797/sanofi-enxtpasan-wins-two-drug-approvals-in-japan-and-the-eu/

https://www.alojapan.com/1502797/sanofi-enxtpasan-wins-two-drug-approvals-in-japan-and-the-eu/ Sanofi (ENXTPA:SAN) Wins Two Drug Approvals In Japan And The EU #ImmuneThrombocytopenia #Japan #JapanNews #MarketedProducts #news #Sanofi Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide. Sanofi secured approval in Japan for Wayrilz (rilzabrutinib) to treat chronic immune thrombocytopenia. Cenrifki (tolebrutinib) received EU approval for progressive mu

Backed by Sanofi and Roche, Orano Med chases radiopharma leadership

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily…
#France #FR #Europe #EU #Sanofi #FrédéricDesdouits #Orano #OranoMed #radioactiveisotope
https://www.europesays.com/france/40174/

Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses

Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disabil…
#France #FR #Europe #EU #Sanofi #approved #as #Cenrifki #disability-targeting #first #for #in #Medicine #multiple #press #progressive #relapses #release #Sanofi’s #sclerosis #secondary #the #tolebrutinib #Without
https://www.europesays.com/france/39708/